These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 32847479

  • 21. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm.
    Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M.
    N Engl J Med; 2019 Apr 25; 380(17):1628-1637. PubMed ID: 31018069
    [Abstract] [Full Text] [Related]

  • 22. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A, Sweet K.
    J Natl Compr Canc Netw; 2023 May 25; 21(5):515-521. PubMed ID: 37156483
    [Abstract] [Full Text] [Related]

  • 23. FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jen EY, Gao X, Li L, Zhuang L, Simpson NE, Aryal B, Wang R, Przepiorka D, Shen YL, Leong R, Liu C, Sheth CM, Bowen S, Goldberg KB, Farrell AT, Blumenthal GM, Pazdur R.
    Clin Cancer Res; 2020 Feb 01; 26(3):532-536. PubMed ID: 31548341
    [Abstract] [Full Text] [Related]

  • 24. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
    Shi J, Xu N, Niu Y, Jia SX, Yang CM, Fang MY.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan 14; 45(1):86-89. PubMed ID: 38527844
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. DNA methyltransferase inhibition overcomes diphthamide pathway deficiencies underlying CD123-targeted treatment resistance.
    Togami K, Pastika T, Stephansky J, Ghandi M, Christie AL, Jones KL, Johnson CA, Lindsay RW, Brooks CL, Letai A, Craig JW, Pozdnyakova O, Weinstock DM, Montero J, Aster JC, Johannessen CM, Lane AA.
    J Clin Invest; 2019 Nov 01; 129(11):5005-5019. PubMed ID: 31437130
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, Gabarin N, Campbell CJV, Duell J, Moshe Y, Mughal T, Mohty M, Angelucci E.
    Clin Lymphoma Myeloma Leuk; 2024 Apr 01; 24(4):e130-e137. PubMed ID: 38267355
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Blastic plasmacytoid dendritic cell neoplasm (BPDCN) : A rare hematologic neoplasm with frequent cutaneous involvement].
    Nguyen K, Korsing S, Mansour Y, Meier K.
    Dermatologie (Heidelb); 2023 Oct 01; 74(10):787-792. PubMed ID: 37407876
    [Abstract] [Full Text] [Related]

  • 39. Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.
    Abla D, Abboud MR, Noun D, Tarek N, Pemmaraju N.
    Leuk Res Rep; 2022 Oct 01; 17():100313. PubMed ID: 35462725
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.